RT Journal Article SR Electronic T1 Assessing the marks of change: how psychotherapy alters the brain structure in women with borderline personality disorder JF Journal of Psychiatry and Neuroscience JO J Psychiatry Neurosci FD Canadian Medical Association SP 171 OP 181 DO 10.1503/jpn.170132 VO 43 IS 3 A1 Falk Mancke A1 Ruth Schmitt A1 Dorina Winter A1 Inga Niedtfeld A1 Sabine C. Herpertz A1 Christian Schmahl YR 2018 UL http://jpn.ca/content/43/3/171.abstract AB Background: There is increasing evidence that psychotherapy can alter the function of the brain of patients with borderline personality disorder (BPD). However, it is not known whether psychotherapy can also modify the brain structure of patients with BPD.Methods: We used structural MRI data of female patients with BPD before and after participation in 12 weeks of residential dialectical behavioural therapy (DBT) and compared them to data from female patients with BPD who received treatment as usual (TAU). We applied voxel-based morphometry to study voxel-wise changes in grey matter volume over time.Results: We included 31 patients in the DBT group and 17 in the TAU group. Patients receiving DBT showed an increase of grey matter volume in the anterior cingulate cortex, inferior frontal gyrus and superior temporal gyrus together with an alteration of grey matter volume in the angular gyrus and supramarginal gyrus compared with patients receiving TAU. Furthermore, therapy response correlated with increase of grey matter volume in the angular gyrus.Limitations: Only women were investigated, and groups differed in size, medication (controlled for) and intensity of the treatment condition.Conclusion: We found that DBT increased grey matter volume of brain regions that are critically implicated in emotion regulation and higher-order functions, such as mentalizing. The role of the angular gyrus for treatment response may reside in its cross-modal integrative function. These findings enhance our understanding of psychotherapy mechanisms of change and may foster the development of neurobiologically informed therapeutic interventions.